Choosing Bispecific T-cell Engager as Third-line and Beyond Therapy for FL
A panel of experts discuss how to choose bispecific T-cell engagers as third-line and beyond therapy for FL.
Recent Updates Follicular Lymphoma Mantle Cell Lymphoma Bispecifict Cell Engager Beyond Therapy Third Line
Source: onclive.com